A phase I pharmacokinetic and safety study of Paclitaxel Injection Concentrate for Nano-dispersion (PICN) alone and in combination with carboplatin in patients with advanced solid malignancies and biliary tract cancers
Year: 2021
Type: article
Study design: Clinical Trial
Institutions: Mayo Clinic, University of Colorado Anschutz, University of Colorado Denver, Roswell Park Comprehensive Cancer Center, Stanford Medicine, Stanford University, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Sun Pharma (India), Sun Pharma Advanced Research (India), The University of Texas at Austin
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3130379178
